It has been shown that, depending on the type of cancer, CacyBP/SIP may act as a tumor suppressor (e.g., kidney, gastric cancer) or oncogene (e.g., pancreatic, colorectal cancer) [9,10,11]. This evidence concerns the gene CACYBP and cancer.